tiprankstipranks
pc:alleg

Allegria Therapeutics

A Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases. Allegria Therapeutics is progressing a differentiated portfolio of proprietary therapeutic approaches and targets to selectively modulate mast cells, aiming to develop transformative therapies for allergies and related inflammatory conditions.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 11, 2025
Seed Round
$5.10M

Investors

Investor Name
Funding Round

Related News and Analysis